Baker Kevin Paul 4
4 · FIVE PRIME THERAPEUTICS INC · Filed Feb 2, 2018
Insider Transaction Report
Form 4
Baker Kevin Paul
SVP, Development Sciences
Transactions
- Tax Payment
Common Stock
2018-02-01$19.73/sh−18,866$372,226→ 75,614 total
4 · FIVE PRIME THERAPEUTICS INC · Filed Feb 2, 2018
Common Stock